Stock transaction disclosure

VRX

Valeant Pharmaceuticals International, Inc. (NYSE)

SC

Collins, Susan

R-MEsenate

Reported action

Purchase

Disclosed amount range

$1,001 - $15,000

Transaction date

Mar 11, 2014

Filing date

May 13, 2015

Reported owner

spouse

Filing timeliness

383 days late

Committee oversight: Member, Senate Committee on Health, Education, Labor, and Pensions (Drug pricing, health insurance, biotech)

Amounts are disclosed ranges, not exact transaction values. Senate coverage is complete; House coverage is partial.

All disclosures for VRX →